Identity
- Security key
- 13587
- Ticker
- CNTX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-10-20
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CNTX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $43,174,025.27
- Shares outstanding (class)
- 91,879,177
- Shares outstanding (weighted)
- 91,879,177
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 15
- Location
- PHILADELPHIA, PA
- Description
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.